Detalles de la búsqueda
1.
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement.
Mol Ther
; 32(4): 1061-1079, 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382529
2.
Clinically relevant Gram-negative resistance mechanisms have no effect on the efficacy of MC-1, a novel siderophore-conjugated monocarbam.
Antimicrob Agents Chemother
; 56(12): 6334-42, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23027195
3.
Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue.
Front Immunol
; 13: 869725, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35784298
4.
Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders.
Transl Res
; 249: 49-73, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35691544
5.
Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular Carcinoma.
ACS Med Chem Lett
; 11(10): 1899-1904, 2020 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33062171
6.
Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim.
Proteins
; 76(3): 706-17, 2009 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19280600
7.
Non-traditional antibacterial screening approaches for the identification of novel inhibitors of the glyoxylate shunt in gram-negative pathogens.
PLoS One
; 7(12): e51732, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23240059
8.
The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases.
Bioorg Med Chem Lett
; 16(9): 2337-40, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16143519
Resultados
1 -
8
de 8
1
Próxima >
>>